By expenditures
| Name | Title | Type |
|---|---|---|
| Ron Fitzherbert | Ceo | Auditee |
| Oscar Loy | Shareholder | Auditee |
| Pamela Angell | CEO | Auditee |
| Joanne Nugent | Shareholder | Auditee |
| Tello Cabrera | Shareholder | Auditee |
| No contacts on file | ||
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 378015 | 2025 | 2025-12-30 | 1166971 | 2025-001 | Material Weakness | Yes | N |
| 378015 | 2025 | 2025-12-30 | 1166970 | 2025-001 | Material Weakness | Yes | N |
| 378015 | 2025 | 2025-12-30 | 1166969 | 2025-001 | Material Weakness | Yes | N |
| 378015 | 2025 | 2025-12-30 | 1166968 | 2025-001 | Material Weakness | Yes | N |
| 378015 | 2025 | 2025-12-30 | 1166967 | 2025-001 | Material Weakness | Yes | N |
| 378015 | 2025 | 2025-12-30 | 1166966 | 2025-001 | Material Weakness | Yes | N |
| 34825 | 2022 | 2023-03-30 | 613350 | 2022-001 | Significant Deficiency | Yes | N |
| 34825 | 2022 | 2023-03-30 | 613349 | 2022-001 | Significant Deficiency | Yes | N |
| 34825 | 2022 | 2023-03-30 | 613348 | 2022-001 | Significant Deficiency | Yes | N |
| 34825 | 2022 | 2023-03-30 | 613347 | 2022-001 | Significant Deficiency | Yes | N |
| 34825 | 2022 | 2023-03-30 | 613346 | 2022-001 | Significant Deficiency | Yes | N |
| 34825 | 2022 | 2023-03-30 | 613345 | 2022-001 | Significant Deficiency | Yes | N |
| 34825 | 2022 | 2023-03-30 | 36908 | 2022-001 | Significant Deficiency | Yes | N |
| 34825 | 2022 | 2023-03-30 | 36907 | 2022-001 | Significant Deficiency | Yes | N |
| 34825 | 2022 | 2023-03-30 | 36906 | 2022-001 | Significant Deficiency | Yes | N |
| 34825 | 2022 | 2023-03-30 | 36905 | 2022-001 | Significant Deficiency | Yes | N |
| 34825 | 2022 | 2023-03-30 | 36904 | 2022-001 | Significant Deficiency | Yes | N |
| 34825 | 2022 | 2023-03-30 | 36903 | 2022-001 | Significant Deficiency | Yes | N |